Chemoinformaics analysis of ANTIARONE H
Molecular Weight | 438.52 | nRot | 6 |
Heavy Atom Molecular Weight | 408.28 | nRig | 20 |
Exact Molecular Weight | 438.204 | nRing | 3 |
Solubility: LogS | -3.98 | nHRing | 1 |
Solubility: LogP | 6.348 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 62 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 2 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 26 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
nHA | 6 | APOL | 68.2358 |
nHD | 3 | BPOL | 34.4362 |
QED | 0.513 |
Synth | 3.595 |
Natural Product Likeliness | 1.959 |
NR-PPAR-gamma | 0.907 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.779 |
Pgp-sub | 0.432 |
HIA | 0.071 |
CACO-2 | -4.872 |
MDCK | 0.0000122 |
BBB | 0.005 |
PPB | 0.896997 |
VDSS | 1.171 |
FU | 0.115717 |
CYP1A2-inh | 0.242 |
CYP1A2-sub | 0.833 |
CYP2c19-inh | 0.95 |
CYP2c19-sub | 0.21 |
CYP2c9-inh | 0.921 |
CYP2c9-sub | 0.949 |
CYP2d6-inh | 0.619 |
CYP2d6-sub | 0.568 |
CYP3a4-inh | 0.312 |
CYP3a4-sub | 0.227 |
CL | 15.907 |
T12 | 0.234 |
hERG | 0.022 |
Ames | 0.023 |
ROA | 0.659 |
SkinSen | 0.933 |
Carcinogencity | 0.073 |
EI | 0.385 |
Respiratory | 0.868 |
NR-Aromatase | 0.768 |
Antiviral | Yes |
Prediction | 0.822368 |